Sun Pharmaceutical Industries informs about press release

23 Jan 2026 Evaluate
Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives DCGI approval to manufacture and market generic semaglutide injection in India for chronic weight management,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Inds. Share Price

1813.00 5.40 (0.30%)
10-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1813.00
Dr. Reddys Lab 1313.90
Cipla 1333.10
Zydus Lifesciences 922.90
Lupin 2340.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×